Breast Imaging

Women's health news related to breast imaging, including mammography, breast MRI, automated breast ultrasound (ABUS), breast ultrasound, breast biopsy, and positron emission mammography (PEM). This channel also includes news on breast density and the issues it causes in detecting cancers.  Mammography can be broken into two types of systems. 2-D full field digital mammography (FFDM) have almost completely replaced older X-ray film based systems. The newest generation systems use 3-D tomosynthesis mammography technology, where a series of digital images are shot in an arch around the breasts and a computer reconstructs the images into slices that can be scrolled through to see layers of tissue. This allows easier radiology reading of images, especially in women with dense breasts, because it can cancers where there are several layers of thick breast tissue that can mask cancers on 2-D mammography. Tomo is rapidly replacing FFDM.

Medical researchers at Flinders University have established a new link between high body mass index (BMI) and breast cancer survival rates — with clinical data revealing worse outcomes for early breast cancer (EBC) patients and improved survival rates in advanced breast cancer (ABC).

Getty Images

News | Women's Health | May 13, 2021
May 13, 2021 — Medical researchers at Flinders University have established a new link between high body mass index (BMI...
Hologic, Inc. launched Project Health Equality (PHE), a unique initiative that strives to address the structural and cultural barriers that prevent Black and Hispanic women in the U.S. from receiving the same quality health care as white women.
News | Women's Health | May 12, 2021
May 12, 2021 — Hologic, Inc. launched Project Health Equality (PHE), a unique initiative that strives to address the...
Videos | Coronavirus (COVID-19) | May 11, 2021
Yael Eshet, M.D., MSc, a diagnostic radiology specialist at Sheba Medical Center in Israel, was the lead author on a...
News | Artificial Intelligence | May 11, 2021
May 11, 2021 — Whiterabbit, an AI technology company focused on early breast cancer detection, today announced the...
A study involving researchers at Karolinska Institutet and Gothenburg University in Sweden has found that low levels of a protein called PDGFRb are associated with particularly good results of radiotherapy in women with early-stage breast cancer.
News | Radiation Therapy | May 11, 2021
May 11, 2021 —A study involving researchers at Karolinska Institutet and Gothenburg University in Sweden has found that...
GE Healthcare announced the acquisition of Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that help enable more personalized healthcare. The company aims to develop and bring to market Zionexa’s pipeline biomarkers, as well as the recently FDA-approved PET imaging agent, Cerianna (fluoroestradiol F-18)
News | PET Imaging | May 06, 2021
May 6, 2021 — GE Healthcare announced the acquisition of Zionexa, a leading innovator of in-vivo oncology and neurology...
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | May 03, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccination effort over the past four months is bringing closer the light at the end of the...
Molli provides breast cancer patients with a better experience over traditional wire and other lesion localization options; the new device helps surgeons remove lesions more efficiently with accuracy and specificity
News | Breast Imaging | May 03, 2021
May 3, 2021 — Molli Surgical Inc. announced U.S. Food and Drug Administration (FDA) clearance for Molli, a new wire-...
Knowledge gaps regarding breast density among women’s health providers can be addressed with web-based education and may lead to more informed and effective patient-provider communications
News | Breast Density | April 28, 2021
April 28, 2021 – DenseBreast-info.org (DB-I) announced the results of the study, “Effect of an educational intervention...
The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

News | Breast Imaging | April 23, 2021
April 23, 2021 — The U.S. Food and Drug Administration (FDA) has approved Seno Medical's Imagio P200003 Breast Imaging...
A Norwegian study for the first time reveals benefit of the #PARP inhibitor #Olaparib in patients with early #breastcancer not harboring germline mutations

Getty Images

News | Radiation Therapy | April 22, 2021
April 22, 2021 — Targeted therapy in early stages of breast cancer can pave the way for a notable higher success rate,...
#SBI #NCoBC Studies presented at two leading breast imaging conferences demonstrate ProFound AI helps radiologists identify normal mammograms and those with increased likelihood of malignancy with precision
News | Breast Imaging | April 22, 2021
April 22, 2021 —iCAD, Inc. announced that new research supporting the clinical value of ProFound AI for Digital Breast...
Women at high risk of breast cancer face cost-associated barriers to care even when they have health insurance, a new study has found.

Getty Images

News | Women's Health | April 22, 2021
April 22, 2021 — Women at high risk of breast cancer face cost-associated barriers to care even when they have health...
#LG Business Solutions USA has announced the latest in LG’s full line of professional, medical-grade #diagnostic #monitors, the 31-inch, 12-megapixel #31HN713D, which can be used for multiple modes of #diagnostic study, including 3-D #mammography.
News | Flat Panel Displays | April 21, 2021
April 21, 2021 — Spurred by the pandemic and the larger trend toward remote work, radiologists have started seeking...
Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

News | Breast Imaging | April 14, 2021
April 14, 2021 — Detecting and analyzing breast cancer goes beyond the initial discovery of the cancer itself. If a...
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.

Getty Images

News | Breast Imaging | April 09, 2021
April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine...
Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, announced today that it has signed a definitive agreement to be acquired by Hologic, Inc., a global leader in women's health, for an enterprise value of approximately $795 million.  This includes a cash payment of approximately $714 million for Mobidiag’s equity, and net debt of approximately $81 million.
News | Women's Health | April 08, 2021
April 8, 2021 — Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular...
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on Cancer of the World Health Organization stated that...
 iCAD, Inc. announced that ProFound AI for 2D Mammography might notably reduce the risk of interval breast cancer, according to a retrospective analysis recently published in the Journal of Medical Screening. 
News | Breast Imaging | April 02, 2021
April 2, 2021 — iCAD, Inc. announced that ProFound AI for 2D Mammography might notably reduce the risk of interval...
While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to discover new approaches to saving lives. A study published in the JAMA Network Open on Thursday, March 25, 2021, recommends a new way for triaging mammogram patients during times of limited capacity, such as pandemic surges, when individuals may also experience anxiety about COVID-19.

Getty Images

News | Breast Imaging | April 01, 2021
April 1, 2021 — While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to...